Prostate Cancer Trial, Recruiting (NCT03784924)

Prostate Cancer Trial, Recruiting NCT03784924 Sponsor: University of Michigan Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03784924 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Men who are suspected of having prostate cancer but have not yet been diagnosed
Men who are already scheduled for, or are due to be scheduled for, a prostate biopsy as part of their normal medical care

Who may not be able to join:

Men from whom blood and urine samples cannot be collected according to the trial's standard procedures, or who cannot have a proper rectal examination performed
Men who are unable to undergo or tolerate a prostate MRI scan, or where the MRI could not be completed
Men who have already been diagnosed with prostate cancer
Men who have had a previous prostate MRI, unless that earlier MRI is being used as the reference scan for this trial (in which case an MRI taken up to one year before the consent date may be accepted — confirm with trial site)
Men who are currently taking part in another clinical trial related to prostate disease
Men who have previously had prostate surgery, including procedures such as TURP, TUNA, TUMT, HoLEP, Rezūm, or UroLift
Men who have previously had certain specific prostate cancer biomarker tests (PCA3, TMPRSS2:ERG, or the MiPS panel) performed for clinical purposes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: John T Wei, MD, MS, University of Michigan

Phone: 206-667-3438

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03784924

Sponsor: University of Michigan

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 206-667-3438

More information: https://clinicaltrials.gov/study/NCT03784924

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Men who are suspected of having prostate cancer but have not yet been diagnosed
Men who are already scheduled for, or are due to be scheduled for, a prostate biopsy as part of their normal medical care

Who may not be able to join:

Men from whom blood and urine samples cannot be collected according to the trial's standard procedures, or who cannot have a proper rectal examination performed
Men who are unable to undergo or tolerate a prostate MRI scan, or where the MRI could not be completed
Men who have already been diagnosed with prostate cancer
Men who have had a previous prostate MRI, unless that earlier MRI is being used as the reference scan for this trial (in which case an MRI taken up to one year before the consent date may be accepted — confirm with trial site)
Men who are currently taking part in another clinical trial related to prostate disease
Men who have previously had prostate surgery, including procedures such as TURP, TUNA, TUMT, HoLEP, Rezūm, or UroLift
Men who have previously had certain specific prostate cancer biomarker tests (PCA3, TMPRSS2:ERG, or the MiPS panel) performed for clinical purposes

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Michigan

Registry

ClinicalTrials.gov

Start date

4 February 2019

Est. completion

30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinically significant prostate cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov